Cartalax
Cartalax is a synthetic short peptide bioregulator derived from cartilage tissue. It supports regeneration of the extracellular cartilage matrix, stimulates fibroblast and chondrocyte activity, and may alleviate symptoms of osteoarthritis and other degenerative joint diseases. Commonly used in short injectable cycles with minimal systemic side effects.
Standard dose: 4 mg SQ daily for 10–20 days. Range: 2–6 mg daily. Repeat cycles every 3–6 months for chronic joint health. Some protocols split into 2–3 smaller daily doses.
Cartilage regenerationCartalaxpeptide bioregulatorjoint repair